Jintropin (recombinant human growth hormone) / GeneScience - LARVOL DELTA

A Bioequivalence Study of Two Different PEG-rhGH Preparations (clinicaltrials.gov) - P1 | N=87 | Active, not recruiting | Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Active, not recruiting

Enrollment closed • Endocrine Disorders • Growth Hormone Deficiency • Growth Hormone Deficiency (Adult) • Growth Hormone Deficiency (Pediatric) • Pediatrics

A Bioavailability Study of Two Different PEG-rhGH Preparations. (clinicaltrials.gov) - P1 | N=16 | Completed | Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Completed | Trial completion date: Dec 2024 ➔ Mar 2025

Trial completion • Trial completion date • Endocrine Disorders • Growth Hormone Deficiency • Growth Hormone Deficiency (Adult) • Growth Hormone Deficiency (Pediatric) • Pediatrics • IGF1

A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations (clinicaltrials.gov) - P1 | N=48 | Completed | Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Completed

Trial completion • Endocrine Disorders • Growth Hormone Deficiency • Growth Hormone Deficiency (Adult) • Growth Hormone Deficiency (Pediatric) • Pediatrics

A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations (clinicaltrials.gov) - P1 | N=60 | Completed | Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Completed

Trial completion • Endocrine Disorders • Growth Hormone Deficiency • Growth Hormone Deficiency (Adult) • Growth Hormone Deficiency (Pediatric) • Pediatrics

A Bioequivalence Study of Two Different Processes of PEG-rhGH Preparations (clinicaltrials.gov) - P1 | N=87 | Not yet recruiting | Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

New P1 trial • Endocrine Disorders • Growth Hormone Deficiency • Growth Hormone Deficiency (Adult) • Growth Hormone Deficiency (Pediatric) • Pediatrics

A Bioequivalence Study of Two Different PEG-rhGH Preparations (clinicaltrials.gov) - P1 | N=87 | Not yet recruiting | Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

New P1 trial • Endocrine Disorders • Growth Hormone Deficiency • Growth Hormone Deficiency (Adult) • Growth Hormone Deficiency (Pediatric) • Pediatrics

Real world study of PEG-rhGH treatment for growth hormone deficiency patients in Western China (ChiCTR) - P4 | N=1000 | Sponsor: Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China; Chengdu Women's and Chi

New P4 trial • Endocrine Disorders • Growth Hormone Deficiency • IGF1

A Real-world Study of Long-acting Growth Hormone Injection for Turner Syndrome (clinicaltrials.gov) - P=N/A | N=743 | Completed | Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

New trial • Real-world • Real-world evidence • Genetic Disorders • Turners Syndrome

A Bioequivalence Study of Two Different PEG-rhGH Preparations. (clinicaltrials.gov) - P1 | N=87 | Completed | Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Completed | Trial completion date: Nov 2024 ➔ Aug 2024

Trial completion • Trial completion date • Endocrine Disorders • Growth Hormone Deficiency • Growth Hormone Deficiency (Adult) • Growth Hormone Deficiency (Pediatric) • Pediatrics

A Study on the Efficacy and Safety of Pegylated Recombinant Human Growth Hormone (Jintrolong®) in Children with Idiopathic Short Stature (ChiCTR) - P4 | N=100 | Not yet recruiting | Sponsor: Children's Hospital,Zhejiang University School of Medicine; Children's Hospital,Zhejiang University School of Medicine

New P4 trial • Idiopathic Short Stature

A Bioavailability Study of Two Different PEG-rhGH Preparations. (clinicaltrials.gov) - P1 | N=16 | Not yet recruiting | Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

New P1 trial • Endocrine Disorders • Growth Hormone Deficiency • Growth Hormone Deficiency (Adult) • Growth Hormone Deficiency (Pediatric) • Pediatrics

A Bioequivalence Study of Two Different PEG-rhGH Preparations. (clinicaltrials.gov) - P1 | N=87 | Not yet recruiting | Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

New P1 trial • Endocrine Disorders • Growth Hormone Deficiency • Growth Hormone Deficiency (Adult) • Growth Hormone Deficiency (Pediatric) • Pediatrics

A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations (clinicaltrials.gov) - P1 | N=48 | Not yet recruiting | Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

New P1 trial • Endocrine Disorders • Growth Hormone Deficiency • Growth Hormone Deficiency (Adult) • Growth Hormone Deficiency (Pediatric) • Pediatrics

A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations (clinicaltrials.gov) - P1 | N=60 | Not yet recruiting | Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

New P1 trial • Endocrine Disorders • Growth Hormone Deficiency • Growth Hormone Deficiency (Adult) • Growth Hormone Deficiency (Pediatric) • Pediatrics

A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants (clinicaltrials.gov) - P4 | N=138 | Recruiting | Sponsor: Tongji Hospital | Not yet recruiting ➔ Recruiting

Enrollment open • Real-world • Real-world evidence • CNS Disorders • Developmental Disorders • Psychiatry • Small for Gestational Age

A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia (clinicaltrials.gov) - P4 | N=38 | Recruiting | Sponsor: GeneScience Pharmaceuticals Co., Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • Genetic Disorders • IGF1 • IGFBP3

A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia (clinicaltrials.gov) - P4 | N=38 | Not yet recruiting | Sponsor: GeneScience Pharmaceuticals Co., Ltd.

New P4 trial • Genetic Disorders • IGF1 • IGFBP3

Phase III clinical study of pegylated somatropin (PEG Somatropin) to treat growth hormone deficiency children (clinicaltrials.gov) - P3, N=343; Completed; New P3 trial

New trial • Growth Hormone